| |
| |
|
| Insider
Information: |
Lawlis V Bryan |
| Relationship: |
Director |
| City: |
Hayward |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
33,140 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,937,198 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
33,140 |
|
|
| Total
Value |
$2,937,198 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2023-05-23 |
33,140 |
2009-05-12 |
0 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2023-05-11 |
0 |
2023-05-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,190 |
33,140 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2023-05-11 |
4 |
AS |
$3.00 |
$105,000 |
D/D |
(35,000) |
0 |
0 |
% |
|
| GERN |
Geron Corporation |
Director |
– • – |
2023-05-11 |
4 |
OE |
$1.10 |
$38,500 |
D/D |
35,000 |
35,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,980 |
28,950 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2022-04-14 |
4 |
AS |
$83.66 |
$355,555 |
D/D |
(4,250) |
23,970 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2022-04-14 |
4 |
OE |
$37.46 |
$159,205 |
D/D |
4,250 |
28,220 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2022-01-14 |
4 |
AS |
$87.61 |
$372,343 |
D/D |
(4,250) |
23,970 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2022-01-14 |
4 |
OE |
$37.46 |
$159,205 |
D/D |
4,250 |
28,220 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,120 |
23,970 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2021-04-15 |
4 |
AS |
$76.90 |
$576,750 |
D/D |
(7,500) |
18,850 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2021-04-15 |
4 |
OE |
$26.49 |
$198,675 |
D/D |
7,500 |
26,350 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2021-02-16 |
4 |
AS |
$87.41 |
$655,575 |
D/D |
(7,500) |
18,850 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2021-02-16 |
4 |
OE |
$26.49 |
$198,675 |
D/D |
7,500 |
26,350 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2020-06-05 |
4 |
AS |
$107.46 |
$476,048 |
D/D |
(4,430) |
18,850 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
23,280 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2020-03-17 |
4 |
AS |
$75.39 |
$282,713 |
D/D |
(3,750) |
18,980 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2020-03-17 |
4 |
OE |
$21.51 |
$80,663 |
D/D |
3,750 |
22,730 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2020-03-16 |
4 |
AS |
$76.52 |
$352,757 |
D/D |
(4,610) |
18,980 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-12-17 |
4 |
AS |
$83.36 |
$312,600 |
D/D |
(3,750) |
23,590 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-12-17 |
4 |
OE |
$21.51 |
$80,663 |
D/D |
3,750 |
27,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-09-17 |
4 |
AS |
$74.47 |
$279,263 |
D/D |
(3,750) |
23,590 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-09-17 |
4 |
OE |
$21.51 |
$80,663 |
D/D |
3,750 |
27,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-06-17 |
4 |
AS |
$81.08 |
$304,050 |
D/D |
(3,750) |
23,590 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-06-17 |
4 |
OE |
$21.51 |
$80,663 |
D/D |
3,750 |
27,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,430 |
23,590 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
